Adult Stem Cells.

Abstract

Within just a few years, the possibility that the human body contains cells that can repair and regenerate damaged and diseased tissue has gone from an unlikely proposition to a virtual certainty. Adult stem cells have been isolated from numerous tissues, umbilical cord, and other non-embryonic sources, and have demonstrated a surprising ability for transformation into other tissue and types and for repair of damaged tissues. This paper will examine the published literature regarding the identity of stem cells and possible mechanisms for their observed differentiation into tissue types other than their tissue of origin. Reported data from both human and animal studies will be presented on the various tissue sources of stem cells and the differentiation and repair abilities for each source, especially with regards to current and potential therapeutic treatments. Adult stem cells have received intense scrutiny over the past few years due to surprising discoveries regarding heretofore unknown abilities to form multiple and tissue types, as well as the discovery of such cells in an increasing number of tissues. The term adult stem cell is somewhat of a misnomer, because the cells are present even in infants and similar cells exist in umbilical cord and placenta. More accurate terms have been proposed, such as tissue stem cells, somatic stem cells, or post-natal stem cells. However, because of common usage this review will continue to use the term stem cell. This paper will review the literature related to stem cells, including current and potential clinical applications (with apologies to the many who are not cited, due to the exponential increase in papers regarding stem cells and the limitations of this review.) The focus will be on human stem cells, but will also include results from animal studies which bear on the potential of stem cells to be used therapeutically for patients. This paper will not attempt to review the literature related to hematopoietic stem cells, i.e., the bone marrow stem that is the immediate precursor for blood cells, and the formation of typical blood cells. Nor will this paper review the substantial literature regarding clinical use of bone marrow or bone marrow stein transplants for hematopoietic conditions such as various cancers and anemias, nor the striking clinical results seen for conditions such as scleromyxedema, multiple sclerosis, systemic lupus, arthritis, Crohn's disease, etc. (1) In these instances, the stem cells are used primarily to replace the hematopoietic system of the patient, after ablation of the patient's own bone marrow hematopoietic system. Finally, multipotent progenitor cells (MAPC'S), a bone marrow stem that has shown significant abilities at proliferation in culture and differentiation into other body tissues, (2) have been reviewed by Dr. Catherine Verfaillie in a separate paper for the President's Council on Bioethics, and the reader is directed to that review for more information. Key questions regarding stem cells are: (1) their identity, (2) their tissue source of origin, (3) their ability to form other or tissue types, and (4) the mechanisms behind such changes in differentiation and effects on tissues and organs. Historically only a few stem cells were recognized in humans, such as the hematopoietic stem which produces all of the blood types, the gastrointestinal stem associated with regeneration of the gastrointestinal lining, the stem responsible for the epidermal layer of skin, and germ precursors (in the human, the spermatogonial stem cell.) These stem cells were considered to have very limited repertoires, related to replenishment of cells within their tissue of origin. These limitations were considered to be a normal part of the developmental paradigm in which cells become more and more restricted in their lineage capabilities, leading to defined and specific differentiated cells in body tissues. …